Chrysosplenol-D, a Flavonol from Artemisia annua, Induces ERK1/2-Mediated Apoptosis in TripleNegative Human Breast Cancer Cells

By Sophia J. Lang, Michael Schmiech, Susanne Hafner, Christian Paetz,Katharina Werner, Menna El Gaafary, Christoph Q. Schmidt, Tatiana Syrovets and Thomas Simmet


Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology

By Shu Qiao Zhang, Hai Bo Xu

Nobel Prize for artemisinin brings phytotherapy into the spotlight

By Thomas Efferth, Susana Zacchino, Milen I. Georgiev, Liang Liu, Hildebert Wagner, Alexander Panossian


Retrospective study of small pet tumors treated with Artemisia annua and iron

By Mohamed E.M. Saeed, Elmar Breuer, Mohamed-Elamir F. Hegazy and Thomas Efferth

Cancer/Leishmania treatment with the ACT-WHO validated LupArte2.0 ® capsules/tablets

By Dr. med. vet. Elmar Breuer

Artemisinin–Second Career as Anticancer Drug?

By Professor Dr. Thomas Efferth (Johannes Gutenberg University, Institute of Pharmacy and Biochemistry, Department of Pharmaceutical Biology, Staudinger Weg 5, 55128 Mainz, Germany.)

Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia Annua

By Dr. med. vet. Elmar Breuer • Professor Dr. Thomas Efferth (Received: 25 February 2014 / Accepted: 1 April 2014 © The Author(s) 2014.)

Artemisia annua and artemisin effects against canine cancer

Link: New-on-pubmed-artemisia-annua-and-artemisinin-effects-against-canine-cancer/

An oxidatively stressful situation: a case of Artemisia annua L.


Kommentare sind geschlossen.